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Abstract  
 
The incidence of epidemic Kaposi’s sarcoma in HIV/AIDS patients is high due to 
their compromised immune system. HIV-positive individuals presenting with cancer 
tend to be more sensitive to ionising radiation and are at a higher risk of developing 
severe side effects during radiotherapy, and there is a need to develop non-invasive 
methods to preferentially sensitise cancer cells and reduce therapeutic doses.  
 
Here, the effects of 100 and 1000 Hz electromagnetic fields (EMF) broadcast via an 
argon plasma ray tube at 50 W on the radiosensitivity of apparently normal Chinese 
hamster lung fibroblasts (V79) and human malignant melanoma cells (MeWo) were 
evaluated using the colony forming assay. Pre-exposure of the fibroblasts to both 
fields had no effect on their radiosensitivity, if X-ray irradiation followed within 2 h or 
at 6 h. Significant radiosensitisation was observed when X-rays were administered 4 
h after EMF exposure. For the MeWo cells, pre-exposure to 100 Hz resulted in a 
significant radioprotection when irradiation followed within 6 h. However, treatment of 
these cells with a 1000 Hz field significantly potentiated the effect of X-rays. When 
cells were irradiated prior to EMF exposure, the V79 cells were marginally protected 
by the 100 Hz field and sensitised by the 1000 Hz field. In contrast, the melanoma 
cells were slightly protected by the 1000 Hz field and sensitised by the 100 Hz field.  
 
The survival rate of the normal fibroblasts when treated with 2 Gy, in two fractions of 
1 Gy 6 h apart, was similar to those obtained when cells received an acute dose of 2 
Gy 6 h prior to or after exposure to both EMF frequencies. On the other hand, the 
melanoma cells were significantly sensitised when they were either treated with a 
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combination of X-rays and then 100 Hz EMF 6 h later or with a combination of either 
of the EMF frequencies and then X-rays 6 h later.  
 
These data suggest that use of electromagnetic fields may sensitise tumours to 
radiation therapy and reduce normal tissue toxicity. Informed and well-designed 
combinations of low-medium frequency electromagnetic fields and radiation therapy 
might be beneficial in the management of cancers, especially epidemic Kaposi’s 
sarcoma.  
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Opsomming 
 
 
Die insidensie van epidemiese Kaposi-sarkoom in pasiënte met MIV/VIGS is hoog 
weens die gekompromitteerde immuunstelsel. MIV-positiewe persone met kanker 
neig om meer gevoelig te wees vir ioniserende bestraling en loop die hoër risiko om 
ernstige nuwe-effekte op te doen gedurende bestraling.  Daar is dus ‘n behoefte om 
nie-indringende metodes te ontwikkel wat kankerselle by voorkeur meer kwesbaar 
maak en daardeur terapeutiese bestralingsdosisse te kan verminder. 
 
Die navorsing illustreer die gevolge van blootstelling aan 100Hz en 1000Hz 
elektromagnetiese velde (EMV), geproduseer deur ‘n argon-plasmastraalbuis van 
50W, op die radiosensitiwiteit van skynbaar normale long-fibroblaste (V79) van 
Chinese hamsters en mens melanoomselle (MeWo), gemeet deur gebruik te maak 
van kolonievormende toetse. Fibroblaste, vooraf blootgestel aan 100Hz en 1000Hz 
elektromagnetiese velde, het geen uitwerking teen bestraling getoon indien die 
bestraling binne 2 en 6 uur plaasgevind het nie. Aansienlike radiosensitiwiteit is 
waargeneem toe X-strale aangewend is 4 uur na EMV-blootstelling. MeWo-selle 
vooraf blootgestel aan 100Hz EMV en binne 6 uur opgevolg met bestraling, het 
opmerklike sensitisering vir bestraling getoon. Behandeling van hierdie selle met ‘n 
1000Hz-veldsterkte het egter die effek van X-strale aansienlik versterk.  Toe selle 
bestraal is voor EMV-blootstelling, is die V79-selle marginaal deur die 100Hz-veld 
beskerm en gesensitiseer deur die 1000Hz-veld. In teenstelling is die melanoomselle 
tot ‘n mate beskerm deur die 1000Hz-veld en gesensitiseer deur die 100Hz-veld. 
 
Die oorlewingstempo van die normale fibroblaste behandel met 2Gy, in twee fraksies 
van 1Gy, ses uur na mekaar, was soortgelyk aan dié toe selle ‘n akute dosis van 
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2Gy ontvang het ses uur voor of na hul blootstelling aan beide EMV-frekwensies. In 
teenstelling, is die melanoomselle merkwaardig gesensitiseer toe hul behandel is 
met ‘n kombinasie van X-strale en dan 100Hz EMV ses uur later, of met ‘n 
kombinasie van die EMV-frekwensies en X-strale ses uur later. 
 
Hierdie data suggereer dat die gebruik van elektromagnetiese velde tumore gevoelig 
mag maak vir stralingsterapie, terwyl dit toksisiteit vir normale weefsel verminder. 
Ingeligte en weldeurdagte kombinasies van laagmediumfrekwensie 
elektromagnetiese velde en stralingsterapie mag moontlik voordelig wees vir die 
behandeling van maligniteite, veral epidemiese Kaposi-sarkoom. 
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1.1. Introduction 
 
Kaposi’s sarcoma (KS) is a skin cancer caused by human herpes virus 8 (HHV8) 
that develops from the cells that line lymph or blood vessels (Jacobson et al., 2000). 
KS usually appears as tumours on the skin or on mucosal surfaces such as inside 
the mouth, but tumours can also develop in other parts of the body. Kaposi’s 
sarcomas can feature as cutaneous lesions with or without internal involvement. The 
high prevalence of HIV/AIDS in sub-Saharan Africa has resulted in a corresponding 
rise in the frequency of HIV/AIDS patients presenting with a co-morbidity of Kaposi’s 
sarcoma (epidemic KS). Epidemic KS lesions often rapidly progress to plaques and 
nodules affecting the upper trunk, face, and oral mucosa. KS is now considered as 
an “AIDS defining” illness. HIV-positive patients are at a greater risk of cancer than 
the general population due to a compromised immune system (Kaminuma et al., 
2010). A weak immune system allows cancer to spread faster in HIV-positive 
patients than it normally would. Non-epidemic Kaposi’s sarcoma is ranked the 6th 
and 8th most common cancer in South African males and females, respectively 
(Jemal et al., 2012). With the increasing burden of HIV/AIDS, the rank of KS, as a 
disease entity, could be even higher. There is, therefore, an urgent need to develop 
novel and effective treatment approaches for Kaposi’s sarcoma, especially in 
HIV/AIDS patients.     
 
The treatment of epidemic Kaposi’s sarcoma, as for any other cancer, is largely 
influenced by factors like disease site and extent, symptoms, and overall patient 
condition. Epidemic KS may be treated by several treatment modalities. The first 
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step in the treatment of epidemic KS should be optimal control of the HIV infection, 
using highly active antiretroviral therapy (HAART) which is known to reduce the 
severity of KS in AIDS patients (Cattelan et al., 2005). HAART alone, however, may 
not reverse progression of KS and other treatments are necessary e.g. surgery, 
chemotherapy, radiation therapy and biological therapy. The highest response rate is 
found with radiation therapy, however, due to their compromised immune system, 
HIV/AIDS patients may not fully recover from the side effects of radiation therapy as 
they may have an inadequate capacity to repair the damage induced by radiation 
(Berson et al., 1990). Radiation therapy can also weaken the immune system, and 
so, patients with HIV/AIDS may not be able to complete the full course of treatment 
without risking severe side effects, such as life threatening infections. Therefore, 
alternative treatment modalities are needed for epidemic Kaposi’s sarcoma.  
 
In light of the current rise in HIV infection and cancer diagnosis in HIV-positive 
individuals, many factors and many methods are in use or being investigated to 
influence radiation sensitivity. One such approach is electromagnetic therapy which 
involves the use of radio waves and other electromagnetic waves. There has been 
an increase in research on the interaction between extremely low frequency 
electromagnetic fields (ELF EMF) and various biological processes since the 
reported association between childhood leukaemia and nearby electrical 
transmission and distribution equipment (Lee et al., 2015). EMFs are shown to have 
an adverse effect on cells, but, as with ionising radiation which is known to be 
carcinogenic and is also used in radiotherapy, EMFs may have an anticancer effect 
on cancer cells (Verginadis et al., 2012). Combination therapy options may lead to a 
reduction in the amount of radiation delivered to a patient during treatment, thus 
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reducing normal tissue toxicity. Pioneering studies over half a century ago 
demonstrated that although radiosensitivity can be altered using modifying agents, a 
given modifying agent does not always change the sensitivity of different cell lines to 
radiation exposure in the same way (Goodrich, 1943). The phenomenon has recently 
been observed whereby dual inhibition of phosphoinositide 3-kinase (PI3K) and 
mammalian target of rapamycin (mTOR) was found to radiosensitise prostate and 
breast cancer cells, but acted as a radioprotector in normal prostate cells and mouse 
gut (Potiron et al., 2013; Hamunyela et al., 2015; Maleka et al., 2015). The main 
objective of radiotherapy is to kill tumour cells, or stop their proliferation, whilst 
protecting normal tissue. Due to an increase in the diagnosis of cancer there has 
been an increased desire to develop novel treatment modalities. Non-ionising 
electromagnetic fields from extremely low frequency to radiofrequency have been 
shown to affect living cells even at low intensities. Some of these effects may be 
applied in medical treatments. The effects of ELF-EMF depend upon frequency, 
amplitude, and length of exposure, and are also related to the intrinsic susceptibility 
and responsiveness of different cell types. Although the mechanism of this 
interaction is still obscure, ELF-EMF can influence cell proliferation, differentiation, 
cell cycle, apoptosis, DNA replication and protein expression (Lucia, 2016; Restrepo 
et al., 2016). It has also been reported that EMFs in conjunction with 
chemotherapeutic agents can reverse the resistance of cancer cells (Verginadis et 
al., 2012; Janigro et al., 2006), with minimal or no side effects, inhibit disease 
progression and prolong patient survival (Barbault et al., 2009; Kirson et al., 2007; 
Verginadis et al., 2012). 
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It is, therefore, possible that low or medium frequency electromagnetic fields could 
potentiate the cytotoxic effects of ionising radiation. The objectives of this study were 
to: (1) test whether the anti-proliferative and anticancer effects of radio frequencies 
can enhance the effectiveness of radiation therapy; and (2) compare the outcomes 
of conventional fractionated radiation therapy and the proposed therapeutic 
approach of combining electromagnetic fields with radiation therapy. 
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1.2. Literature Review 
 
1.2.1. Epidemiology 
 
Kaposi’s sarcoma (KS) was first described by Moritz Kaposi in 1872 (Kaposi, 1872). 
Since then, four variants of KS have been described, namely, classic/Mediterranean, 
African/endemic, post transplantation, and epidemic/AIDS-associated. Epidemic KS 
was first discovered in 1981 in males who had had sex with other males and it is 
more common in individuals with HIV/AIDS (Beral et al., 1990; Krigel and Friedman-
Kien, 1990). Epidemic KS is usually marked by the appearance of widespread 
lesions in different parts of the body, sometimes causing painful swelling of the feet 
and lower legs. Examples of various types of Kaposi’s sarcoma are presented in 
Figures 1.1 and 1.2 (Hengge et al., 2002). Given that Kaposi’s sarcoma, and 
especially epidemic KS, tends to be markedly disseminated and rarely localised, 
multiple treatment approaches are desirable in order to effectively manage the 
disease. 
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Figure1.1: Different forms of KS. A: classic KS; B: epidemic KS; C: immunosuppression KS; D: 
endemic African KS (Hengge et al., 2002). 
 
 
 
Figure 1.2: Manifestations of epidemic KS. A: multiple livid, irregular papules and plaques. B: purple-
black nodules and tumours on the chest in Christmas tree-like distribution along Blaschko’s lines. C: 
mucous membrane involvement with reddish tumours and livid plaques on the upper gum. D: well 
demarcated plaque on the tip of the glans penis (Hengge et al., 2002). 
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1.2.2. Gene Involvement in Epidemic Kaposi’s Sarcoma  
 
Kaposi’s sarcoma is initially a cytokine-driven proliferative process. Cytokine 
receptors, including interleukins 1, 2, 6 and 8, and tumour necrosis factor have been 
demonstrated on KS spindle cells (Cianfrocca and Roenn, 1998; Miles, 1993). 
Studies have also suggested that the trans-activator of transcription (TAT) gene of 
the HIV activates the vascular endothelial growth factor receptor 2 on KS cells 
(Ganju et al., 1988; Morini et al., 2000; Deregibus et al., 2002). Deregibus et al. 
found that, in Kaposi’s sarcoma cells, the TAT gene enhances transcription of 
several anti-apoptotic genes, such as, serine-threonine protein kinase-1 (AKT-1), 
AKT-2, anti-apoptotic B-cell lymphoma-2 (BCL-2), B-cell lymphoma-extra large 
(BCL-XL), and insulin-like growth factor 1 (IGF-1). Even though the pro-apoptotic 
genes of the BCL family, such as BAX and BAD, are upregulated in Kaposi’s 
sarcoma, the overall effect is protection from apoptosis. It is also suggested that the 
phosphoinositide 3-kinase (PI3K)/AKT pathway is involved in TAT-mediated anti-
apoptotic effects (Deregibus et al., 2002). The HIV TAT gene product is mitogenic for 
KS spindle cells in vitro and may promote the development and progression of 
epidemic KS (Ensoli et al., 1994; Cianfrocca and Roenn, 1998). These factors can, 
therefore, lead to treatment resistance in Kaposi’s sarcoma, necessitating the 
development of new and more effective therapeutic approaches.   
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1.2.3. Treatment Options for Epidemic Kaposi’s Sarcoma  
 
1.2.3.1. Radiation Therapy  
 
The highest treatment response rate in Kaposi’s sarcoma patients is obtained with 
radiation therapy. However, due to a compromised immune system HIV/AIDS 
patients may experience significantly higher level side effects, as they may present 
with an inadequate capacity to repair radiation-induced damage (Berson et al., 
1990). Some investigators suggest a single dose of 8 Gy as optimal for all cases of 
cutaneous KS (Berson et al., 1990; Stelzer and Griffin, 1993). Such a high dose may 
cause high tissue toxicity which HIV/AIDS patients may not recover from. 
Conventional fractionated radiation therapy (given as 20 Gy in 10 fractions or 40 Gy 
in 20 fractions) has also been used to treat KS in HIV/AIDS patients, and it was 
noted that acute toxicity increased with increasing radiation dose (Stelzer and Griffin, 
1993). On the other hand, a single dose of 8 Gy causes less normal tissue toxicity 
than the conventional regimens. Electron beam therapy (given as 4 Gy weekly 
fractions) has also been used in patients with widespread skin involvement and has 
been found to be effective in controlling disease (Nobler et al., 1987; Cooper, 1991; 
Escalon and Hagemeister, 2006). As the number of HIV/AIDS patients presenting 
with KS is on the increase and patients are expected to exhibit lower levels of 
treatment tolerance compared to their non-AIDS infected counterparts, combining 
radiation therapy with other modalities might be beneficial for epidemic Kaposi’s 
sarcoma patients.  
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1.2.3.2. Other Therapies 
 
Other therapeutic endeavours may be summarised as follows (Escalon and 
Hagemeister, 2006): Surgical excision alone, or in combination with laser therapies 
can be used to palliate small superficial lesions, but this method may not be as 
effective in deep bulky lesions. Cryotherapy may be a useful treatment option for 
small facial lesions less than 1 cm in diameter, but is not ideal for large deep lesions. 
Topical retinoids which are available commercially and generally well-tolerated may 
also be used to treat Kaposi’s sarcoma, but may cause local erythema and irritation. 
There has also been a significant level of interest in targeting of the vascular 
endothelial growth factor (VEGF) and the mammalian target of rapamycin (mTOR) 
pathways with inhibitors as a regimen for treating Kaposi’s sarcoma.  
 
1.2.4. Medical Applications and Biological Effects of Electromagnetic Fields 
 
Electromagnetic fields (EMF) have been used to successfully treat ailments, such as, 
wounds, bone fractures, and depression (Bassett et al., 1981; Bassett, 1985; 
Artacho-Cordón et al., 2013; Cheing et al., 2014). There is a significant level of 
evidence to show that electromagnetic fields, such as electric, magnetic, and 
radiofrequency (RF) fields, in conjunction with chemotherapeutic agents, can reverse 
the resistance of cancer cells (Janigro et al., 2006; Verginadis et al., 2012; Tofani, 
2015), as well as, synergistically cause genetic effects (Cho et al., 2007; Koyama et 
al., 2008; Markkanen et al., 2008). Most entities that interact synergistically with 
EMFs are mutagens, and thus the synergism between EMFs and X-rays should be 
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considered more seriously. Electromagnetic fields have been shown to inhibit 
disease progression and prolong patient survival with minimal or no side effects 
(Kirson et al., 2007; Barbault et al., 2009; Verginadis et al., 2012).  
 
In vitro studies have also shown that extremely low frequency magnetic fields can 
affect cell death processes like apoptosis (Simkó et al., 1998; Tofani et al., 2001; 
Sarimov et al., 2005; Crocetti et al., 2013; Tofani, 2015). Magnetic fields penetrate 
cells unattenuated and can thus interact directly with the DNA in the nucleus and 
other cell constituents (Blank and Goodman, 2009). There is overwhelming evidence 
supporting the opinion that exposure to magnetic fields has an effect on cellular 
functions, such as, transcription, protein synthesis, proliferation, and differentiation. 
Cellular exposure to magnetic field intensities of 0.38-19 mT has been shown to lead 
to increased transcription of c-myc and histone H2A (Goodman and Henderson, 
1991). This can significantly impact on the net cellular response to the field 
exposure. While c-myc plays an important role in cell cycle regulation and cell death, 
histone H2A is central in DNA damage repair.  
 
Although apoptotic cell death has been shown to occur in WiDr cells at field 
intensities greater than 1.0 mT, tumour regression in nude mice bearing WiDr 
tumours was evident only at much higher intensities (Tofani et al., 2001). Anti-tumour 
and immune modulatory activity has also been demonstrated in mouse melanoma 
and hepatocellular carcinoma models for magnetic fields of 0.25 and 0.4 T, 
respectively (Yamaguchi et al., 2006; Nie et al., 2013). The retardation of tumour 
growth by electromagnetic fields appears to be correlated with their capacity to 
suppress tumour vascularisation (Cameron et al., 2014). Acute exposure to field 
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intensities below 1.0 mT does not exhibit anti-proliferative activity, but results in 
increased level of reactive oxygen species (ROS) (Morabito et al., 2010), which may 
ultimately mediate cellular responses to other cytotoxic agents like chemotherapeutic 
drugs and ionising radiation.  
 
Electric fields with intensities of 1.0–1.4 V/cm can alter the cell membrane structure 
leading to changes in the permeability of ions, such as Ca2+, cause changes in the 
local pH and temperature, reorganise cytoskeletal components, and disrupt 
microtubule polymerisation (Kirson et al., 2004; Sulpizio et al., 2011; Lee et al., 
2015). Exposing cells to electric fields can also cause modifications in gene 
expression and free radical production which affects DNA structure and provokes 
strand-breaks and other chromosomal aberrations, such as micronucleus formation 
and oxidative response (Kirson et al., 2004; Wolf et al., 2005; Vijayalaxmi and 
Prihoda, 2009; Buldak et al., 2012; Artacho-Cordón et al., 2013; Deng et al., 2013; 
Luukkonen et al., 2014; Mattsson and Simkó, 2014; Lee et al., 2015; Li et al., 2015). 
In addition, electric fields can physically affect the movement and orientation of 
electrically charged molecular entities (Singh et al., 1997; Menéndez, 1999). EMF 
exposure can also lead to an increase in the density of phosphorylated receptors on 
the surfaces of cell membranes (Del Monache et al., 2008). The membrane is 
believed to be the primary site for electromagnetic field interaction (Singh et al., 
1997). 
 
An extremely low frequency magnetic field of 1.0 mT has been suggested to induce 
immune cell activation through three different pathways, namely, the classical 
activation, the alternative activation and the lectin-dependent activation pathways 
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(Lupke et al., 2006). The classical activation pathway includes activation of 
inflammatory responses, destruction of extracellular matrix and induction of 
apoptosis. The alternative activation pathway promotes extracellular matrix 
construction, cell proliferation, resolves inflammation, and angiogenesis. The lectin-
dependent activation pathway also initiates inflammation and apoptosis and inhibits 
cell growth in a way comparable to the classical activation (Lupke et al., 2006). All 
the perturbations exerted by electromagnetic fields ultimately exert anti-proliferative 
and anticancer effects by influencing cell cycle progression, the rate of cell 
proliferation, differentiation, tubulin polymerisation, antioxidant activity and apoptosis 
(Kirson et al., 2004; 2007; Wolf et al., 2005; Polaniak et al., 2010; Zimmerman et al., 
2013; Artacho-Cordón et al., 2013; Butters et al., 2014; Lee et al., 2015; Ross et al., 
2015).  
 
Other reports have indicated that EMFs may induce genetic effects without the 
involvement of free radicals (Ferreira et al., 2006; Alcaraz et al., 2014; Furtado-Filho 
et al., 2013). EMF exposure has been shown to increase the expression levels of the 
VEGF receptor, KDR/Flk-1, in normal human umbilical vein endothelial cells (Del 
Monache et al., 2008). Intermittent powerline magnetic field exposure to 5 min 
ON/30 min OFF cycles at a flux density of 2.3 mT for 6 h also resulted in a significant 
upregulation of p21 and egr-1 mRNA levels in p53-deficient, but not wild-type cells 
(Czyz et al., 2003). Electromagnetic fields have also been shown to modulate the 
activity of hormones, antibodies, neurotransmitters and oncogenes at their surface 
receptor sites (Singh et al., 1997). These perturbations of important biomolecules by 
electromagnetic fields could act as precursors for better response of cancer to other 
therapies.  
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The aforementioned therapeutic potential of electromagnetic fields, notwithstanding 
the application of plasma ray tubes (the so-called Rife Frequency Generator) in the 
treatment of cancer, largely remains a controversial issue. Over two decades ago, 
the American Cancer Society discouraged the use of devices, such as the Rife 
frequency generator for cancer therapy, due to paucity of experimental and scientific 
evidence (American Cancer Society, 1994). However, the concept of targeting pro-
survival genes with characteristic resonant frequencies broadcast from a Rife device 
to induce cell death was recently demonstrated in a colon cancer cell line (Agulan et 
al., 2015). Also, a significant level of evidence exists for effectively targeting 
malignancies with cancer-specific radiofrequency electromagnetic fields 
(Zimmerman et al., 2013).  
 
1.2.5. Rationale for Using Electromagnetic Fields for Cancer Therapy 
 
Cellular exposure to a 60 Hz magnetic field can cause DNA single and double 
strand-breaks (Lai and Singh, 1997a), DNA-protein and DNA-DNA crosslinks (Singh 
and Lai, 1998), and increased apoptosis (Lai and Singh, 2004). Removal of iron from 
cellular systems using iron chelators have been shown to eliminate the cytotoxic 
effects of magnetic fields (Lai and Singh, 1997b). The aforementioned findings led to 
the proposal that magnetic fields generate free radicals via the Fenton reaction as 
depicted in Figure 1.3 (Lai and Singh, 2010). In this reaction, the interaction between 
an EMF and hydrogen peroxide released from mitochondria is catalysed by iron to 
yield highly reactive species, such as the hydroxyl radical (OH).  These species, if 
not adequately picked up by scavengers, can damage DNA by causing single or 
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double strand-breaks (Lai and Singh, 2010; Ruediger, 2009). Cancer cells, by virtue 
of their high rate of proliferation, have a much higher rate of iron intake than their 
normal counterparts (Lai and Singh, 2010). As the production of free radicals is 
correlated to iron content, it is conceivable that cancer cells would be more 
responsive to magnetic field exposure than normal cells. Therefore, the use of 
electromagnetic fields in cancer therapy might a viable option.   
 
 
 
 
 
Figure 1.3: The Fenton reaction: conversion of hydrogen peroxide (H2O2) into a highly reactive 
hydroxyl radical (OH) in the presence of iron (Lai and Singh, 2010). 
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1.3. Problem Statement 
 
Kaposi’s sarcoma (KS) is a skin cancer caused by human herpes virus 8 that 
develops from the cells that line lymph or blood vessels. Currently, the incidence of 
KS co-morbidity in HIV/AIDS patients is high due to their compromised immune 
system. HIV-positive individuals presenting with cancer are treated in much the 
same way as those who do not have HIV through surgery, chemotherapy, radiation 
therapy and biological therapy. These therapeutic approaches can put HIV-positive 
cancer patients at a higher risk of developing severe side effects that they may not 
recover from. Radiotherapy, in particular, has proven to be the most effective 
regimen for managing Kaposi’s sarcoma. However, given that HIV-positive patients 
by virtue of their compromised immune system tend to experience significantly 
higher levels of treatment related toxicity, there is an urgent need to develop non-
invasive methods to sensitise cancer cells (or tumours) to therapeutic doses of 
ionising radiation. Such procedures should significantly lower the doses of radiation 
required to yield a given level of tumour control and, therefore, reduce toxicity to 
normal tissue.    
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1.4.  Hypothesis 
 
 
It is hypothesised that in vitro exposure of cancer cells to low or intermediate 
frequencies of electromagnetic waves (e.g. radio-frequency waves) can preferentially 
increase their radiosensitivity. 
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1.5. Aims and Objectives 
 
This study aimed to assess the potential therapeutic benefit of combining 
electromagnetic fields with radiation therapy in an in vitro setting, using lung 
fibroblasts and melanoma cells. 
  
To achieve this specific aim, the study objectives are as follows: 
 
1. To determine the radiosensitivity of Chinese hamster lung fibroblasts (V79) 
and human melanoma cells (MeWo) following acute and fractionated 
irradiation.  
2. Compare cellular response to acute and fractionated X-ray irradiation, in order 
to establish capacity of cell lines to repair radiation-induced damage.  
3. To evaluate the influence of radio-frequency electromagnetic fields (EMF) on 
radiosensitivity, in order to determine the EMF frequency, sequence, and time 
interval relative to X-ray irradiation to yield the highest and least 
radiosensitisation in the melanoma cells (MeWo) and fibroblasts (V79), 
respectively. 
4. To compare results from the best combination of EMF exposure and X-ray 
irradiation with those from fractionated irradiation. 
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2. Materials and Methods 
 
2.1. Cell Lines and Culture 
 
V79 
The V79 cell line (ATCC® Number: CCL-93™) was established from the lung of a 
Chinese hamster. These cells have a fibroblast-like morphology and were used to 
represent normal tissue. The culture was obtained from Flow Laboratories (Irvine, 
Scotland). The cells were cultivated as monolayers in 75 cm2 flasks in Minimum 
Essential Medium (MEM) supplemented with 10% foetal bovine serum, penicillin 
(100 U/ml), streptomycin (100 µg/ml) and incubated at 37°C in a humidified 
atmosphere (95% air, 5% CO2). Cells were used for experiments upon reaching 80-
90% confluence. 
 
MeWo 
The human melanoma cell line (MeWo) (ATCC® Number: HTB-65™) was kindly 
provided by F. Zölzer and C. Streffer (University of Essen, Germany). The cells were 
cultivated as monolayers in 75 cm2 flasks in minimum essential medium (MEM) 
supplemented with 20% foetal bovine serum, penicillin (100 U/ml), streptomycin (100 
μg/ml) and incubated at 37°C in a humidified atmosphere (95% air, 5% CO2). Cells 
were used for experiments upon reaching 80-90% confluence. 
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2.2. Cell Culture Irradiation and Clonogenic Cell Survival 
 
Exponentially growing cell cultures were trypsinised into single-cell suspensions and 
seeded in varying numbers into 25 cm2 tissue culture flasks, dependent on the cell 
line and the level of absorbed radiation dose. The final volume of culture medium in 
each flask was 10 ml. Table 2.1 summarises the cell numbers that were plated for 
each dose and cell line. For each experiment and dose point, triplicate cell culture 
flasks were prepared. 
 
Table 2.1: Summary of number of cells seeded at each radiation dose of X-rays delivered acutely. 
 
Cell line 0 Gy 1 Gy 2 Gy 4 Gy 6 Gy 8 Gy 10 Gy 
V79 300 300 300 1000 4000 6000 7000 
MeWo 300 300 500 2000 4000 5000 6000 
 
 
The cells were left to settle for 3 h (for V79) and 4 h (for MeWo) after which they 
were irradiated with X-rays. Cell culture irradiation was performed at room 
temperature (20°C) at a dose rate of 1 Gy/min, using a Faxitron MultiRad 160 X-ray 
irradiator (Faxitron Bioptics, Tucson, AZ, USA; Figure 2.1). Sham-irradiated cultures 
(0 Gy cultures) were left on the turntable of the Faxitron X-ray irradiator for 2 min 
with the X-ray source turned off, and were used as controls. The cell cultures were 
then left in an incubator at 37°C for 7 and 14 days (for V79 and MeWo, respectively) 
for colony formation.  
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Figure 2.1: Photograph of the Faxitron MultiRad 160 X-ray irradiator (door opened) showing cell 
culture flasks on the turntable.   
 
To terminate cultures, the growth medium was decanted and colonies were washed 
with phosphate buffered saline, fixed in glacial acetic acid:methanol:water (1:1:8, 
v/v/v), stained in 0.01% amido black in fixative, washed in tap water, air-dried, and 
counted using a stereoscopic microscope (Nikon, Japan; Model #: SMZ-1B). 
Colonies containing at least 50 cells were deemed to have originated from single 
surviving cells and were scored. Cytotoxicity was assessed on the basis of a 
surviving fraction (SF) which was calculated from the relation: 
SF=ncol(t)/{[ncol(u)/ncell(u)]ncell(t)}, where ncol(t) and ncol(u) denote the number of 
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colonies counted in treated and untreated samples, respectively. ncell(t) and ncell(u) 
are the number of cells seeded in treated and untreated cultures, respectively.  
Three independent experiments were performed for each cell line. To generate 
clonogenic cell survival curves, the determined mean surviving fractions were fitted 
to the linear-quadratic (LQ) model of the form: 
 
𝑆𝐹 = exp⁡[−D − 𝐷2]    (1) 
 
α and β are the linear and quadratic cell inactivation constants, respectively, and D is 
the absorbed dose in Gy. Cellular radiosensitivity was expressed in terms of the 
surviving fraction at 2 Gy (SF2). 
 
2.3. Radiation Dose Fractionation Assay 
 
To evaluate the capacity of the cell lines to recover from radiation insult, cells were 
seeded into 25 cm2 tissue culture flasks in numbers as depicted in Table 2.2 for 
subsequent irradiation to 2, 3, and 4 Gy, and the flasks were split into two sets. After 
allowing cells to attach, one set of flasks received two fractions of 1, 1.5, and 2 Gy 6 
h apart, while the other set received 2, 3, and 4 Gy, respectively, as a single fraction. 
The time interval of 6 h was chosen as it is the optimum period used in the clinic 
when two fractions are to be administered in a day. Sham-irradiated cultures (0 Gy 
cultures) were used as controls. For each experiment and dose point, triplicate cell 
culture flasks were prepared. After colony formation, the cultures were terminated 
and the colonies were scored to determine the surviving fractions (SF) at the total 
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doses administered. Cellular capacity to recover from radiation damage (repair 
capacity) was expressed in terms of a recovery index as follows: 
𝑅𝑒𝑐𝑜𝑣𝑒𝑟𝑦⁡𝐼𝑛𝑑𝑒𝑥 =
𝑆𝐹(𝑓𝑟𝑎𝑐𝑡𝑖𝑜𝑛𝑎𝑡𝑒𝑑⁡𝑑𝑜𝑠𝑒)
𝑆𝐹(𝑎𝑐𝑢𝑡𝑒⁡𝑑𝑜𝑠𝑒)
    (2). 
 
Table 2.2: Summary of number of cells seeded at each radiation dose of X-rays delivered acutely or 
as a split dose. 
 
Cell line 0 Gy 2 Gy 3 Gy 4 Gy 
V79 200 200 300 300 
MeWo 400 400 400 400 
 
  
2.4. Experimental Set-Up for Electromagnetic Field Generation and Exposure 
 
Electromagnetic fields were generated using an EMEM oscillator amplifier, to 
produce 27.125 MHz fields, square-wave amplitude-modulated at 100 or 1000 Hz, 
with a peak-to-peak amplitude of 5 V (EMEM Devices Rife Machine, Model #: 1-
2012B, Boulder, CO, USA). The modulating frequencies were generated using a 
GME frequency generator with an output impedance of 50 Ω and a duty cycle of 
50% (GME Technology, Model #: SG-10, Pomona, CA, USA). The resulting 
radiofrequency (RF) was then broadcast via a double bubble argon plasma ray tube 
(length = 25 cm; external diameter = 6.7 cm). The set-up for EMF exposure of cell 
cultures through a plasma Rife tube is illustrated in Figure 2.2. A maximum of 24 cell 
culture flasks could be exposed at a given time, and were stacked in groups of four, 
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such that the outside dimensions of the volume occupied by the cell culture layers 
was 11 cm (Width: 2 flasks breadthwise) × 18 cm (Length: 2 flasks lengthwise) × 14 
mm (Height: 6 flasks by height). The perpendicular distances from the axis of the 
plasma tube to the cell culture planes were 10.0, 12.4, 14.8, 17.2, 19.6, and 22.0 cm. 
Each cell layer was covered with 3.5 mm (10 ml) of culture medium.  
 
To estimate the magnetic and induced electric fields in the cell cultures, the plasma 
ray tube was assumed to function as an antenna that is transmitting at ~27.12 MHz. 
Near field magnetic field strengths for this frequency can vary between 0.5 A/m 
(magnetic flux density of 0.63 T) and 0.8 A/m (magnetic flux density of 1.0 T) at a 
radial distance of 12 cm from the antenna (Mantiply et al., 1997). Therefore, by 
adopting the maximum magnetic flux density of 1.0 T as the peak flux density in the 
plane 12 cm from the axis of the plasma tube (Figure 2.2B), the magnetic flux 
densities in cell culture planes at 10.0 to 22.0 cm were deduced using the inverse-
square law. 
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Figure 2.2: (A) Photograph of the electromagnetic field (EMF) exposure system. (B) A 2-dimensional 
schematic diagram showing the top and bottom cell culture planes of the 226 flask matrix. In the 
set-up, the plasma ray tube is centred horizontally above the cell culture flasks, such that the induced 
magnetic field (B) is parallel to the base of a flask and the induced electric field (E) in the culture 
medium is parallel to the width of the flask.  
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The corresponding induced peak electric fields (V/m) were then calculated as Epeak = 
2hπfB (Bassen et al., 1992), where B is the peak value peak magnetic flux density 
(T), f is the transmitted frequency in (27.125  106 Hz), and 2h is the depth of the cell 
culture medium (0.0035 m). Thus, the estimated magnetic flux densities in the cell 
cultures ranged from 0.30 to 1.44 T, and the corresponding peak electric fields 
varied between 0.09 and 0.42 V/m (Table 2.3).  
 
Table 2.3: Estimated peak magnetic flux density (B), electric field (E), and current density (J) induced 
at a distance (d) from the axis of a 25-cm plasma ray tube. 
 
 
 
Using a conductivity (σ) of 1.5 S/m for the cell culture medium (Bassen et al., 1992), 
induced current densities (J) were calculated from the relation J = σE. Estimated 
current densities in cell cultures ranged from 0.14 to 0.63 A/m2 (Table 2.3). Since the 
ratio of the depth to the width (0.05 m) of the culture medium in each flask is less 
than 0.3, estimation of peak electric fields from the magnetic flux densities has an 
uncertainty of ≤1% (Bassen et al., 1992). For sham-EMF exposure (0 Hz), the 
control samples were treated as described with the plasma ray tube turned off.  
d (cm) B (T)  E (V/m)  J (A/m
2) 
10.0  1.44 0.42 0.63 
12.4 0.94 0.28 0.42 
14.8 0.66 0.20 0.30 
17.2 
19.2 
22.0  
0.49 
0.39 
0.30 
0.15 
0.12 
0.09 
0.23 
0.18 
0.14 
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To test whether the radial variation in induced magnetic flux density across the cell 
culture layers had an impact on cell viability, the proportions of seeded cells that 
eventually form colonies (plating efficiencies) were determined in cell cultures placed 
at the different radial distances, as in Figure 2.2, for 0, 100, and 1000 Hz exposures. 
In the current setting, no significant frequency- and location-dependent differences in 
plating efficiency were observed. For the V79 cells, the plating efficiency at 0 Hz (73 
 4%) did not differ significantly from those at 100 Hz (82  3%; P = 0.12) and 1000 
Hz (73  5%; P = 0.94). Similarly, the plating efficiency for sham exposed MeWo 
cells (55  4%) was not significantly different from those determined when the cells 
were exposed to 100 Hz (62  7%; P = 0.30) and 1000 Hz (57  6%; P = 0.82).  
 
2.5. Radiomodulatory Effects of Electromagnetic Frequencies 
 
To investigate the influence of EMF exposure on radiosensitivity, stock cell cultures 
were trypsinised and 200-500 cells seeded per 25 cm2 tissue culture flask and left to 
settle for 3-4 h (depending on the cell line). The cells were subsequently exposed to 
an electromagnetic field as described under Section 2.4 for 30 min prior to or 
following an X-irradiation of 2 Gy at time points of 0, 0.5, 1, 2, 4, and 6 h. The final 
volume of culture medium in each flask was 10 ml. For each experiment and dose 
point, triplicate cell culture flasks were prepared. Unirradiated cultures with and 
without electromagnetic field exposure were used as controls for EMF and X-ray 
treatment, respectively. For sham-EMF exposure, unirradiated cell cultures were 
treated as described in Figure 2.2 with the plasma ray tube turned off. Three 
independent experiments were performed for each time point and experimental arm. 
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Radiosensitivity was expressed in terms of the surviving fraction at 2 Gy. The 
interaction between EMF and X-rays was expressed as a modifying factor (MF), 
given as the ratio of surviving fractions at 2 Gy in the absence and presence of EMF: 
 
𝑀𝐹 =
𝑆𝐹(2⁡𝐺𝑦)
𝑆𝐹(𝐸𝑀𝐹+2⁡𝐺𝑦)
⁡⁡⁡⁡⁡⁡   (3). 
 
The criteria for inhibition, no effect, and enhancement of radiosensitivity by EMFs are 
MF<1.0, MF=1.0, and MF>1.0, respectively. 
 
2.6. Statistical Analysis 
 
Statistical analyses were performed using the GraphPad Prism (GraphPad Software, 
San Diego, CA, USA) computer program. To compare two data sets, the unpaired 
two-sided t-test was used. A P-value of less than 0.05 indicates a statistically 
significant difference between the data sets. Data were presented as the mean 
(±SEM) from at least 3 independent experiments. For each experiment, 3 replicates 
were assessed. 
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3. Results 
 
3.1. Radiosensitivity 
 
The cellular radiosensitivity was determined using the clonogenic cell survival assay. 
Cell survival data for the V79 and MeWo cell lines were fitted to the linear quadratic 
model (Equation 1) and are presented in Figure 3.1. 
 
 
 
Figure 3.1: Clonogenic survival curve for the V79 and MeWo cell lines after X-ray irradiation. The 
survival curve was obtained by fitting experimental data to the linear-quadratic model (Equation 1). 
 
 
From the dose-response curves, it is apparent that the MeWo cell line is more 
radiosensitive than the V79 cell line. This is consistent with the relatively steeper 
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survival curve for MeWo than for V79. The linear and quadratic coefficients of cell 
inactivation (- and β-coefficients) for the MeWo and V79 cells were found to be 0.29 
± 0.04 Gy-1 and 0.050 ± 0.005 Gy-2 and 0.07 ± 0.02 Gy-1 and 0.029 ± 0.003 Gy-2, 
respectively (Table 3.1). The larger α-coefficient of the MeWo cells also reflects their 
higher radiosensitivity relative to the V79 cells. For a direct dose-related comparison, 
intrinsic cellular radiosensitivity was expressed in terms of the surviving fraction at 2 
Gy (SF2). The V79 cell line was found to be more radioresistant than the MeWo cell 
line. The SF2-values emerged as 0.77 ± 0.04 and 0.45 ± 0.04 for V79 and MeWo, 
respectively, and were significantly different (P = 0.0318). 
 
 
Table 3.1: Summary of radiobiological parameters for Chinese hamster lung fibroblasts (V79) and 
human melanoma cells (MeWo). SF2 denotes the surviving fraction at 2 Gy.  and β are the linear 
and quadratic coefficients of cell inactivation, respectively. Data are presented as the mean ± SEM 
from 3 independent experiments. 
 
 
 
 
3.3 . Cellular Response to Radiation Dose Fractionation 
 
The data presented in Figure 3.2 show that the V79 cells had a better survival when 
they were exposed to 2 and 3 Gy, given in two fractions 6 h apart than when they 
were irradiated with a single full dose. However, the differences in the rates of 
Cell line SF2   (Gy
-1) β (Gy
-2) 
V79 0.77 ± 0.04 0.07 ± 0.02 0.029 ± 0.003 
MeWo 0.45 ± 0.04 0.29 ± 0.04  0.050 ± 0.005 
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recovery at these doses were not statistically significant (P = 0.1016 for 2 Gy; P = 
0.0765 for 3 Gy). At a total dose of 4 Gy, no difference was apparent between cell 
survival for the fractionated and single dose deliveries (P = 0.2379). The recovery 
indices (RI) as defined by Equation 2 emerged as 1.17, 1.18 and 1.04 for total doses 
of 2, 3 and 4 Gy, respectively (Table 3.2). This further proves that the net recovery of 
these cells from damage induced by the first fraction prior to delivery of the second is 
minimal.  
  
 
 
Figure 3.2. Surviving fractions for Chinese hamster lung fibroblasts (V79) following X-ray irradiation, 
either as acute doses (D Gy) or split doses (0.5D Gy per fraction) given 6 h apart. 
 
 
Similarly, the melanoma cells (MeWo) show a better survival rate when exposed to 
split doses, 6 h apart, than for acute irradiation (Figure 3.3). This recovery 
phenomenon was seen at total doses of 2, 3, and 4 Gy, although the differences in 
cell survival between split and acute dose delivery were statistically significant for the 
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higher doses (P = 0.0046 for 3 Gy; P = 0.03 for 4 Gy). The corresponding recovery 
indices at total doses of 2, 3, and 4 Gy were 1.18, 1.61, and 1.48 (Table 3.2). The 
relatively larger RI-values of the melanoma cells (MeWo) is an indication that these 
cells recover more efficiently than the lung fibroblasts (V79).      
 
 
 
Figure 3.3: Surviving fractions for human melanoma cells (MeWo) following X-ray irradiation, either 
as acute doses (D Gy) or split doses (0.5D Gy per fraction) given 6 h apart. 
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Table 3.2: Summary of radiosensitivity and recovery data for Chinese hamster lung fibroblasts (V79) 
and human melanoma cells (MeWo), following acute and fractionated (two fractions with 6-hour 
interval) irradiation. SF and RI denote the surviving fractions and cell recovery indices, respectively 
(Equation 2). 
 
Cell line Treatment SF *  RI 
#  
 
 
 
V79 
2 Gy  0.673 ± 0.014  
1 Gy + 1 Gy 0.788 ± 0.037 1.17 ± 0.06 
3 Gy 0.475 ± 0.025   
1.5 Gy + 1.5 Gy 0.562 ± 0.003 1.18 ± 0.06 
4 Gy 0.388 ± 0.001   
2 Gy + 2 Gy 0.405 ± 0.010 1.04 ± 0.03 
 
 
 
MeWo 
2 Gy  0.511 ± 0.022  
1 Gy + 1 Gy 0.602 ± 0.010 1.18 ± 0.05 
3 Gy 0.240 ± 0.010   
1.5 Gy + 1.5 Gy 0.386 ± 0.001 1.61 ± 0.07 
4 Gy 0.128 ± 0.011   
2 Gy + 2 Gy 0.190 ± 0.002 1.48 ± 0.13 
*Mean ± SEM. 
#
Mean ± error: errors were calculated using appropriate error propagation formulae. 
 
 
3.3. Modulation of Radiosensitivity by Electromagnetic Fields 
 
Radiosensitivity was expressed in terms of the surviving fraction at 2 Gy. Figure 3.4 
shows the relationship between radiosensitivity of the Chinese hamster lung 
fibroblasts (V79) and the time of X-ray treatment after electromagnetic field (EMF) 
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exposure. For time intervals of 0−2 h, exposure to fields of 100 and 1000 Hz 
appeared to have no effect on radiosensitivity, with a modifying factor of ~0.99 as 
shown in Table 3.3. No effect on radiosensitivity was also apparent when cells were 
irradiated 6 h after EMF exposure (Figure 3.4). However, the cells were marginally 
sensitised when X-ray irradiation occurred 4 h after EMF treatment, giving modifying 
factors of 1.08 ± 0.11 and 1.22 ± 0.22 for the 100 and 1000 Hz fields, respectively.  
 
 
 
Figure 3.4: Clonogenic cell survival at 2 Gy in Chinese hamster lung fibroblasts (V79), when cells 
were exposed to a 100 or 1000 Hz electromagnetic field (EMF) prior to X-irradiation, as a function of 
time between EMF exposure and X-ray treatment. Data points are means ± SEM of 3 independent 
experiments. Horizontal dashed line represents the surviving fraction at 2 Gy without EMF exposure. 
 
 
Irradiating V79 cells to 2 Gy prior to exposure to a 100 Hz field yielded a small 
radioprotection, while a 1000 Hz field exposure resulted in a slight radiosensitisation 
(Figure 3.5). The corresponding modifying factors ranged from 0.87−0.96 and 
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1.05−1.13. These effects seemed to be independent of the time interval between X-
ray irradiation and EMF exposure. 
 
 
 
 
Figure 3.5: Clonogenic cell survival at 2 Gy in Chinese hamster lung fibroblasts (V79), when cells 
were exposed to X-irradiation prior to a 100 or 1000 Hz electromagnetic field (EMF), as a function of 
time between X-ray treatment and EMF exposure. Data points are means ± SEM of 3 independent 
experiments. Horizontal dashed line represents the surviving fraction at 2 Gy without EMF exposure.  
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Table 3.3: Summary of radiation dose modifying data for Chinese hamster lung fibroblasts (V79) 
when cells were exposed to EMF (100 and 1000 Hz) prior to or after a 2-Gy X-ray irradiation. MF 
denotes radiation modifying factor (Equation 3). 
 
Treatment Time interval (h)  MF 
#  
 
 
 
 
EMF before X-rays 
 
 
 100 Hz 1000 Hz 
0 0.98 ± 0.06 0.97 ± 0.10 
0.5 1.05 ± 0.10  0.98 ± 0.12 
1 0.99 ± 0.06 0.98 ± 0.10 
2 1.01 ± 0.10 0.99 ± 0.11 
4 1.08 ± 0.11 1.22 ± 0.22 
6 0.98 ± 0.07 1.00 ± 0.09 
 
 
 
X-rays before EMF  
 
0 0.92 ± 0.05 1.06 ± 0.09 
0.5 0.96 ± 0.06 1.13 ± 0.09 
1 0.92 ± 0.06 1.11 ± 0.07 
2 0.93 ± 0.09 1.07 ± 0.09 
4 0.91 ± 0.06 1.05 ± 0.07 
6 0.87 ± 0.06 1.10 ± 0.13 
#
Mean ± error: errors were calculated using appropriate error propagation formulae. 
 
 
Data for cell survival at 2 Gy in the human melanoma cells (MeWo), when cells were 
exposed to either a 100 or 1000 Hz electromagnetic field before being irradiated with 
X-rays, are presented in Figure 3.6. For all time intervals between EMF and X-ray 
treatment, pretreatment with a 100 Hz field resulted in significant radioprotection, 
with modifying factors ranging from 0.68 ± 0.07 to 0.79 ± 0.07. On the contrary, pre-
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exposure to a 1000 Hz field yielded significant radiosensitisation, giving modifying 
factors between 1.35 ± 0.11 and 1.60 ± 0.21. The radiation modifying factors when 
cells were irradiated at 2 h and 4 h after exposure emerged as 1.60 and 1.52, 
respectively (Figure 3.6; Table 3.4). When the MeWo cells were irradiated to 2 Gy of 
X-rays followed by exposure to a 100 Hz EMF, the cells were rendered more 
radiosensitive, as shown in Figure 3.7, with modifying factors ranging from 
1.17−1.33. However, when X-ray exposure was followed by treatment with a 1000 
Hz EMF, the cells were less radiosensitive with modifying factors ranging from 0.90-
0.95. 
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Figure 3.6: Clonogenic cell survival at 2 Gy in human melanoma cells (MeWo), when cells were 
exposed to a 100 or 1000 Hz electromagnetic field (EMF) prior to X-irradiation, as a function of time 
between EMF exposure and X-ray treatment. Data points are means ± SEM of 3 independent 
experiments. Horizontal dashed line represents the surviving fraction at 2 Gy without EMF exposure. 
 
 
 
Figure 3.7: Clonogenic cell survival at 2 Gy in human melanoma cells (MeWo), when cells were 
exposed to X-irradiation prior to a 100 or 1000 Hz electromagnetic field (EMF), as a function of time 
between X-ray treatment and EMF exposure. Data points are means ± SEM of 3 independent 
experiments. Horizontal dashed line represents the surviving fraction at 2 Gy without EMF exposure. 
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Table 3.4: Summary of radiation dose modifying data for human melanoma cells (MeWo) when cells 
were exposed to EMF (100 and 1000 Hz) prior to or after a 2-Gy X-ray irradiation. MF denotes 
radiation modifying factor (Equation 3). 
 
Treatment Time interval (h)  MF 
#  
 
 
 
 
EMF before X-rays 
 
 
 100 Hz 1000 Hz 
0 0.71 ± 0.07 1.36 ± 0.22 
0.5 0.68 ± 0.07  1.35 ± 0.11 
1  0.69 ± 0.08 1.50 ± 0.15 
2  0.70 ± 0.07 1.60 ± 0.21 
4  0.67 ± 0.07 1.52 ± 0.13 
6 0.79 ± 0.07 1.50 ± 0.26 
 
 
 
X-rays before EMF  
 
0 1.33 ± 0.27 0.95 ± 0.13 
0.5 1.17 ± 0.33 0.92 ± 0.08 
1  1.33 ± 0.31 0.90 ± 0.12 
2  1.27 ± 0.41 0.88 ± 0.12 
4  1.33 ± 0.49 0.92 ± 0.08 
6 1.27 ± 0.53 0.93 ± 0.10 
#
Mean ± error: errors were calculated using appropriate error propagation formulae. 
 
 
3.4. Fractionation versus Combination of X-Rays and EMF 
 
To test whether fractionated radiotherapy is superior to combining a single dose of 
radiation with electromagnetic field exposure, surviving fractions at 2 Gy given in two 
fractions 6 h apart were compared with those obtained when cells were treated with 
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a combination of 2 Gy of X-rays and an EMF of 100 Hz or 1000 Hz. The data 
presented in Figure 3.8 show similar levels of survival when the V79 cells were 
treated with either a split dose of X-rays or with an acute dose followed by exposure 
to a 100 Hz EMF 6 h later. Cell survival rates when cells were exposed to EMF (at 
100 or 1000 Hz) 6 h prior to a 2 Gy irradiation or primed with a dose of 2 Gy before 
exposure to 1000 Hz EMF were similar and comparable to that obtained for an acute 
dose of 2 Gy alone.  
 
 
Figure 3.8: Surviving fractions for Chinese hamster lung fibroblasts (V79) following various treatment 
protocols. Split doses of X-rays (1 Gy per fraction) or an acute dose (2 Gy) and EMF exposure were 
given 6 h apart. 
 
 
For the melanoma cell line (MeWo), a 2 Gy irradiation followed by exposure to 1000 
Hz EMF or priming with a 100 Hz EMF before a 2 Gy treatment yielded similar levels 
of cell survival as for the split irradiation (Figure 3.9). However, these cells were 
sensitised when they were irradiated with 2 Gy and then exposed to a 100 Hz EMF 
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albeit not significantly (P = 0.2069). Pre-exposure to a 1000 Hz EMF markedly 
radiosensitised the MeWo cells (P = 0.0195).  
 
 
 
Figure 3.9: Surviving fractions for human melanoma cells (MeWo) following various treatment 
protocols. Split doses of X-rays (1 Gy per fraction) or an acute dose (2 Gy) and EMF exposure were 
given 6 h apart. 
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CHAPTER 4 
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4. Discussion 
 
Radiation therapy (RT) is considered the first line of treatment for most skin cancers 
as these malignancies tend to respond very well. Radiation therapy may be used 
alone or in combination with chemotherapy, surgery or other treatment modalities in 
skin cancer treatment. Radiation therapy has, however, been discouraged in 
younger patients because of an increased risk of developing other consequential 
cancers later in life. The cosmetic side effect of radiation therapy and its 
carcinogenic consequences have led to RT being underutilised, as dermatologists 
tend to focus on the consequences rather than the benefits of RT. HIV/AIDS patients 
with Kaposi’s sarcoma (KS) often suffer from disease-related pain and other 
cosmetic disorders which at times cause them emotional distress (Kirova et al., 
1998; Donato et al., 2013). Although radiation therapy has good palliative outcome, 
these immunocompromised individuals tend to be at very high risk of treatment-
related toxicity. It is, therefore, essential to minimise damage to normal tissue to 
avoid the associated mental distress. This may be achieved by employing adjuvant 
approaches that can help to significantly reduce the amount of radiation dose 
delivered to the patient.  
 
4.1. Intrinsic and Fractionated Radiosensitivity  
 
This study sought to compare the outcomes of a split dose of radiation and an acute 
dose given in conjunction with electromagnetic fields, using Chinese hamster lung 
fibroblasts (V79) and human melanoma cells (MeWo). The disparity in intrinsic 
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radiosensitivity in these cell lines (Figure 3.1) cannot be attributed to differences in 
the status of the p53 gene, as the gene is mutated in both cell lines (Albino et al., 
1994; Chaung et al., 1997). Radiation-induced cell death is not necessarily 
dependent on p53 status (Clarke et al., 1993). The higher radiosensitivity of MeWo 
cells relative to V79 cells is, therefore, likely due to activation of other genes 
upstream of p53 (e.g. ATM) that are responsible for p53-independent cell death in 
the former cell line (Zhivotovsky and Kroemer, 2004), making the cells more 
radiosensitive.  
 
The split-dose data presented in Figures 3.2 and 3.3 show that the melanoma cells 
recover better from radiation-induced damage relative to their V79 counterparts. 
However, there appears to be no significant difference in the capacity of MeWo and 
V79 to rejoin DNA double strand-breaks (Gauter et al., 2002). The efficiency with 
which cells rejoin DNA double strand-breaks correlates with their radiosensitivity 
(Akudugu et al., 2004). The finding that the malignant melanoma cells (MeWo) 
recover to a larger extent than the apparently normal Chinese hamster lung 
fibroblasts (V79) seems to suggest that conventional fractionated radiation therapy 
alone might not be very beneficial for patients presenting with lesions like epidemic 
Kaposi’s sarcoma.  
 
4.2. Modulation of Radiosensitivity by Electromagnetic Fields 
 
To partly address the need for alternative treatment strategies for the 
immunocompromised cohort of cancer patients, the influence of electromagnetic 
fields on cellular radiosensitivity was evaluated. The current data suggest that 
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normal tissue and cancerous cells do not respond to all electromagnetic fields in the 
same way. While pre-exposure of the V79 cells to both 100 and 1000 Hz fields 
followed by 2 Gy of X-rays appears to have no effect when cells were irradiated 
within 2 h of EMF exposure, significant radioprotection and radiosensitisation was 
seen in the MeWo cells for the 100 and 1000 Hz fields over all time points 
investigated (Figures 3.6 and 3.7). The findings that the apparently normal 
fibroblasts appeared to be protected by the 1000 Hz field exposure when cells were 
irradiated 1 h after EMF exposure and that both fields were radiosensitising at an 
interval of 4 h, suggest that an EMF of 1000 Hz may potentiate tumour 
radiosensitivity with little or no normal tissue effect if radiation is given within 1 h of 
EMF exposure.  
 
Interestingly, the 100 Hz field appeared to protect and sensitise pre-irradiated V79 
and MeWo cells, respectively (Figures 3.5 and 3.7). This phenomenon, over all time 
points, indicated that exposing tumour cells to a 100 Hz electromagnetic field within 
6 h of administering a fraction of radiation dose might have a significant level of 
therapeutic benefit. It is currently not clear why these cell lines behave differently 
when exposed to the two electromagnetic fields, and in a manner dependent on the 
sequence of EMF exposure and X-irradiation. However, sensitisation of the cells 
when they are exposed to EMF followed by X-ray could be due to many different 
mechanisms, including the EMF causing an influx of calcium ions, with an alteration 
in homeostasis triggering mitotic division (Pinton et al., 2008). This process would 
prompt otherwise dormant cells to start dividing. Actively dividing cells are more 
prone to radiation-induced cell death than dormant cells, and the net effect will be a 
low level of cell survival. Also, the observed radiosensitisation may have been 
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caused by intracellular cascades, such as activation of matrix metalloproteinases by 
reactive oxygen species (ROS), the concentration of which is known to be increased 
by exposure to magnetic fields (Lai and Singh, 2010; Morabito et al., 2010). ROS act 
as radiosensitisers. Furthermore, the radiosensitisation can result from calcium-ion 
overload, which is highly toxic and leads to cell suicide, by activating proteases and 
phospholipases (Pinton et al., 2008; Artacho-Cordón et al., 2013). Cells carrying 
radiation-induced DNA damage can be expected to be more radiosensitive when 
exposed to EMF, as the electromagnetic field can disorient charged amino acids, 
resulting in a change in the 3-dimensional structure of proteins and thus disturbing 
their function (Menéndez, 1999). This could be a reason for the sensitisation seen 
when cells are exposed to EMF after X-irradiation, since the enzymes responsible for 
repairing X-ray damage may be rendered non-functional by the subsequent 
exposure to appropriate resonant frequencies (Agulan et al., 2015). This can result in 
non-repaired damage and ultimate cell death. However, this cannot explain the 
radiosensitisation seen 6 h after X-irradiation (Figures 3.5 and 3.7), as most all DNA 
repair should be completed. The radiosensitisation seen when pre-irradiated cells 
were exposed to EMF may be due to dysregulation of ion channels and alteration of 
hormones leading to cells adopting different signalling pathways, some of which may 
trigger cell death (Orrenius et al., 1992). Cells become more radiosensitive when 
more damage is inflicted on them by another form of treatment. These findings can 
also be attributed to cells being rendered sensitive to cell type specific 
radiofrequency fields (Zimmerman et al., 2013). 
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4.3. Fractionation versus Combination of X-Rays and EMF 
 
The data summarised in Figure 3.8 indicate that the recovery exhibited in the 
fractionated irradiation by the V79 cells is paralleled by an enhancement in survival 
when cells received an acute dose of 2 Gy and were exposed to a 100 Hz EMF 6 h 
later. Interestingly, the MeWo cells were sensitised in relation to their recovery rate 
from the split dose when they were similarly treated with a combination X-rays and 
the 100 Hz EMF (Figure 3.9). This suggests that a 30 min exposure to a 100 Hz 
EMF 6 h after a 2 Gy fraction may be beneficial to HIV/AIDS with epidemic KS, as 
radiosensitisation of tumours will likely be accompanied by a reduced normal tissue 
toxicity. Exposure of the fibroblasts to both frequencies of EMF followed by a 2 Gy 
irradiation 6 h later had no effect on their intrinsic radiosensitivity at 2 Gy (Figure 
3.8). However, the cell survival rates were lower than when cells were treated with 
split doses. For this treatment protocol, the melanoma cells were significantly 
sensitised when compared with their intrinsic radiosensitivity and recovery rate 
(Figure 3.9). It is, thus, conceivable that patients with epidemic KS could greatly 
benefit from treatment approaches that employ informed and well-designed 
combinations of radiation therapy and electromagnetic field exposures.  
  
Stellenbosch University  https://scholar.sun.ac.za
50 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
 
 
 
 
CHAPTER 5 
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5. Conclusion 
 
There is a great need for the standardisation of electromagnetic field (EMF) therapy 
so that it may be applied in cancer treatment as it is a non-invasive method that has 
a potential to replace or enhance other therapeutic modalities, like radiation therapy, 
surgery and chemotherapy. As the number of HIV/AIDS cases continues to rise, 
epidemic Kaposi’s sarcoma cases are also on the increase. Radiation therapy plays 
a palliative role, and combining it with EMF therapy may even lead to better 
treatment outcomes. The data reported here demonstrate that electromagnetic fields 
appear to have the desirable toxic and protective effects on tumour and normal cells, 
respectively, if appropriate frequencies are administered at the right times relative to 
X-irradiation. Electromagnetic fields, therefore, have the potential of being used in 
conjunction with radiotherapy to reduce the total radiation absorbed dose 
administered to patients. This can have a significant positive impact on the 
management of patients with superficial tumours, especially those who are 
immunocompromised. The use of EMF in combination with radiation therapy may 
yield better results than conventional fractionated radiation therapy.  
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Possible Future Avenues 
To fully harness the potential of electromagnetic fields (EMF) as potentiators of 
radiation therapy, the following avenues need to be explored as they may lead to 
observations other than those reported here: 
1. EMF exposure time could be extended to periods longer than 30 min.  
2. The time between EMF and X-ray exposures can be increased to more than 6 h.  
3. The dose of X-rays used with EMF exposure could also be varied. 
4. Use western blotting techniques to evaluate the effect of EMF on gene 
expression, as this might give an insight into the molecular factors responsible 
for the pro-survival and pro-death effects seen here. 
5. The use of a wider range of human cell lines (normal and malignant). 
6. Experimentation on the effect of EMF on radiosensitivity when X-ray irradiation is 
delivered in more than one fraction.  
7. Use of flow cytometry to determine the mode of cell death induced by the 
combined EMF/X-ray treatment. 
8. Investigate possible synergy between chemotherapy drugs (e.g. cisplatin), X-
rays, and EMF.  
9. Assess cell viability and proliferative state using methods like the 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) tetrazolium 
reduction assay. 
10. Monitor superoxide dismutase/glutathione activity following exposure to EMF 
and X-ray to assess the role of oxidative stress in induced cytotoxicity. 
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1 
 
Abstract— The incidence of Kaposi’s sarcoma co-morbidity in 
HIV/AIDS patients is high due to their compromised immune 
system. HIV-positive individuals presenting with cancer tend to 
be more sensitive to ionizing radiation and are at a higher risk of 
developing severe side effects during radiotherapy, and there is a 
need to develop non-invasive methods to sensitize cancer cells 
and reduce therapeutic doses. Here, the effects of 100 and 1000 
Hz electromagnetic fields (EMF) on the radiosensitivity of 
Chinese hamster lung fibroblasts (V79) and human malignant 
melanoma cells (MeWo) were evaluated using the colony forming 
assay. The induced magnetic flux densities in cell cultures ranged 
from 0.05 to 0.25 T. Pre-exposure of the fibroblasts to both 
fields had no effect on their radiosensitivity, if X-ray irradiation 
followed within 2 h or at 6 h. Significant radiosensitization was 
observed when X-rays were administered 4 h after EMF 
exposure. For the MeWo cells, pre-exposure to a 100 Hz field 
resulted in a significant radioprotection when irradiation 
followed within 6 h. However, treatment of these cells with a 1000 
Hz field significantly potentiated the effect of X-rays. When cells 
were irradiated prior to EMF exposure, the V79 cells were 
marginally protected by the 100 Hz field and sensitized by the 
1000 Hz field. In contrast, the melanoma cells were slightly 
protected by the 1000 Hz field and sensitized by the 100 Hz field. 
These data suggest that informed combination of low-medium 
frequency electromagnetic fields and radiotherapy might be 
beneficial in the management of cancers, especially those 
presented by HIV-positive patients.   
 
Index Terms— Electromagnetic fields, Kaposi’s sarcoma, 
melanoma, radiomodulatory effects, plasma ray tube.  
 
I. INTRODUCTION 
APOSI’S sarcoma (KS) usually appears as tumors on the 
skin or on mucosal surfaces, such as the inner lining of 
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the mouth. KS is now considered as an “AIDS defining” 
illness. HIV-positive patients are at a greater risk of cancer 
than the general population due to a compromised immune 
system [1]. Kaposi’s sarcoma is ranked the 6th and 8th most 
common cancer in South African males and females, 
respectively [2], and can be treated with surgery, 
chemotherapy, radiotherapy, or biological therapy. 
Chemotherapy and radiotherapy can also weaken the immune 
system, and so, people with HIV/AIDS may not be able to get 
full courses of cancer treatment without risking severe side 
effects, such as life-threatening infections. The HIV-positive 
subset of patients also tends to show higher normal tissue 
toxicity during conventional radiotherapy than their HIV-
negative counterparts.  
Pioneering studies over half a century ago demonstrated 
that although radiosensitivity can be altered using modifying 
agents, a given modifying agent does not always change the 
sensitivity of different cell lines to radiation exposure in the 
same way [3]. This phenomenon has been recently observed 
whereby a dual inhibition of phosphoinositide 3-kinase (PI3K) 
and mammalian target of rapamycin (mTOR) was found to 
radiosensitize prostate and breast cancer cells, but acted as a 
radioprotector in normal prostate cells and mouse gut [4]-[6]. 
The main objective of radiotherapy is to kill tumor cells, or 
stop their proliferation, whilst protecting normal tissue. Due to 
an increase in the diagnosis of cancer there has been an 
increased desire to develop novel treatment modalities. 
In light of the current rise in HIV infection and cancer 
diagnosis in HIV-positive individuals, combination therapy 
options may lead to a reduction in the amount of radiation 
delivered to a patient during treatment, thus reducing normal 
tissue toxicity. Reduction in radiation dose during 
radiotherapy is especially of essence for immune 
compromised patients who are known to be more 
radiosensitive [1]. It has also been extensively reported that 
electromagnetic fields (EMF), such as electric, magnetic, and 
radiofrequency (RF) fields, in conjunction with 
chemotherapeutic agents can reverse the resistance of cancer 
cells [7], [8]. These fields have been shown to inhibit disease 
progression and prolong patient survival with minimal or no 
side effects [8]-[10]. Other studies have also shown that 
extremely low frequency magnetic fields can affect cell death 
processes like apoptosis [11]-[13]. Magnetic fields penetrate 
cells unattenuated and can thus interact directly with the DNA 
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2 
in the nucleus and other cell constituents [14]. There is 
overwhelming evidence supporting the opinion that exposure 
to magnetic fields has an effect on cellular functions, such as, 
transcription, protein synthesis, proliferation, and 
differentiation. Cellular exposure to magnetic flux densities of 
0.38-19 mT has been shown to lead to increased transcription 
of c-myc and histone H2A [15]. These field-induced changes 
in transcription activity can significantly impact the net 
cellular response. While c-myc plays an important role in cell 
cycle regulation and cell death, histone H2A is central in DNA 
damage repair. Although apoptotic cell death has been shown 
to occur in WiDr cells at magnetic flux densities greater than 
1.0 mT, tumor regression in nude mice bearing WiDr tumors 
was evident only at much higher intensities [12]. Anti-tumor 
and immune modulatory activity has also been demonstrated 
in a melanoma mouse model for a magnetic flux density of 
0.25 T [16]. Acute exposure to flux densities below 1.0 mT 
does not exhibit anti-proliferative activity, but results in 
increased level of reactive oxygen species [17], which may 
ultimately mediate cellular responses to other cytotoxic agents 
like chemotherapeutic drugs and ionizing radiation. 
Electromagnetic fields have also been used to successfully 
treat ailments, such as, wounds, bone fractures, and depression 
[18]-[19]. Electric fields with intensities ranging from 1.0 to 
1.4 V/cm can alter the cell membrane structure leading to 
changes in the permeability of ions, such as Ca
2+
, cause 
changes in the local pH and temperature, reorganizing 
cytoskeletal components, and disrupting microtubule 
polymerization [20]. Exposing cells to electric fields can also 
cause modifications in gene expression and free radical 
production which affects DNA structure and provokes strand-
breaks and other chromosomal aberrations, such as 
micronucleus formation [20]. In addition, electric fields can 
physically affect the movement and orientation of electrically 
charged molecular entities.  
An extremely low frequency magnetic field with a flux 
density of 1.0 mT has been suggested to induce immune cell 
activation through three different pathways, namely, the 
classical activation, the alternative activation and the lectin-
dependent activation pathways [21]. The classical activation 
pathway includes activation of inflammatory responses, 
destruction of extracellular matrix and induction of apoptosis. 
The alternative activation pathway promotes extracellular 
matrix construction, cell proliferation, resolves inflammation, 
and angiogenesis. The lectin-dependent activation pathway 
also initiates inflammation and apoptosis and inhibits cell 
growth in a way comparable to the classical activation [21]. 
All the perturbations exerted by electromagnetic fields 
ultimately exert anti-proliferative and anticancer effects by 
influencing cell cycle progression, the rate of cell 
proliferation, and apoptosis [9], [18], [20]. 
The aforementioned therapeutic potential of 
electromagnetic fields, notwithstanding the application of 
plasma ray tubes (the so-called Rife Frequency Generator) in 
the treatment of cancer, largely remains a controversial issue. 
Over two decades ago, the American Cancer Society 
discouraged the use of devices, such as the Rife frequency 
generator for cancer therapy, due to paucity of experimental 
and scientific evidence [22]. However, the concept of 
targeting pro-survival genes with characteristic resonant 
frequencies broadcast from a Rife device to induce cell death 
was recently demonstrated in a colon cancer cell line [23]. 
Also, a significant level of evidence exists for effectively 
targeting malignancies with cancer-specific radiofrequency 
electromagnetic fields [24].  
To test whether the anti-proliferative and anticancer effects 
of frequencies broadcast from a Rife device could potentiate 
the cytotoxic effects of ionizing radiation, radiomodulatory 
effects of low or medium frequency electromagnetic fields 
were evaluated in Chinese hamster lung fibroblasts (V79 cells) 
and human melanoma cells (MeWo cells). The potential 
benefit of such a therapeutic approach to immune 
compromised patients with superficial cancers is discussed.  
II. MATERIAL AND METHOD 
A. Cell Lines and Culture 
The V79 cell line was established from the lung of a 
Chinese hamster and has a fibroblast-like morphology. These 
cells were used to represent normal tissue. The culture was 
obtained from Flow Laboratories (Irvine, Scotland). The 
human melanoma cell line (MeWo) was kindly provided by F. 
Zölzer and C. Streffer (University of Essen, Germany). The 
cells were cultivated as monolayers in 75-cm
2 
flasks in 
Minimum Essential Medium (MEM) supplemented with 20% 
foetal bovine serum (10% for V79 cells), penicillin (100 
U/ml), streptomycin (100 µg/ml) and incubated at 37°C in a 
humidified atmosphere (95% air, 5% CO2). Cells were used 
for experiments upon reaching 80 to 90% confluence. For 
experiments, cell cultures were trypsinized and 200 to 500 
cells seeded per 25-cm
2
 tissue culture flask, and left to settle 
for 2 to 4 h (depending on cell line). The cells were 
subsequently exposed to an electromagnetic field for 30 min 
prior to or following an X-ray irradiation at time points of 0, 
0.5, 1, 2, 4, and 6 h. The final volume of culture medium in 
each flask was 10 ml. 
 
B. Electromagnetic Field Generation and Exposure 
Electromagnetic fields were generated using an EMEM 
oscillator amplifier, to produce 27.125 MHz fields, square-
wave amplitude-modulated at 100 or 1000 Hz, with a peak-to-
peak amplitude of 5 V (EMEM Devices Rife Machine, Model 
#: 1-2012B, Boulder, CO). The modulating frequencies were 
generated using a GME frequency generator with an output 
impedance of 50  and a duty cycle of 50% (GME 
Technology, Model #: SG-10, Pomona, CA). The resulting 
radiofrequency (RF) was then broadcast via a double bubble 
argon plasma ray tube (length = 25 cm; external bubble 
diameter = 6.7 cm). The set-up for EMF exposure of cell 
cultures through a plasma Rife tube is illustrated in Fig. 1. A 
maximum of 24 cell culture flasks could be exposed at a given 
time, and were stacked in groups of four, such that the outside 
dimensions of the volume occupied by the cell culture layers 
Page 2 of 13Transactions on Plasma Science
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Stellenbosch University  https://scholar.sun.ac.za
For Review Only
> REPLACE THIS LINE WITH YOUR PAPER IDENTIFICATION NUMBER (DOUBLE-CLICK HERE TO EDIT) < 
 
3 
was 11 cm (Width: 2 flasks breadthwise)  18 cm (Length: 2 
flasks lengthwise)  14 cm (Height: 6 flasks by height). The 
perpendicular distances from the axis of the plasma tube to the 
cell culture planes were 10.0, 12.4, 14.8, 17.2, 19.6, and 22.0 
cm. Each cell layer was covered with 3.5 mm (10 ml) of 
culture medium. 
To estimate the magnetic and induced electric fields in the 
cell cultures, the plasma ray tube was assumed to function as 
an antenna that is transmitting at ~27.12 MHz. Near field 
magnetic field strengths for this frequency can vary between 
0.5 A/m (magnetic flux density of 0.63 T) and 0.8 A/m 
(magnetic flux density of 1.0 T) at a radial distance of 12 cm 
from the antenna [25]. Therefore, by adopting the maximum 
magnetic flux density of 1.0 T as the peak flux density in the 
plane 12 cm from the axis of the plasma tube (Fig. 1B), the 
magnetic flux densities in cell culture planes at 10.0 to 22.0 
cm were deduced using the inverse-square law. The 
corresponding induced peak electric fields (V/m) were then 
calculated as Epeak = 2hπfB [26], where B is the peak value 
peak magnetic flux density (T), f is the transmitted frequency 
in (27.125 × 10
6
 Hz), and 2h is the depth of the cell culture 
medium (0.0035 m). Thus, the estimated magnetic flux 
densities in the cell cultures ranged from 0.30 to 1.44 T, and 
the corresponding peak electric fields were 0.09 to 0.42 V/m 
(Table I). Using a conductivity () of 1.5 S/m for the cell 
culture medium [26], induced current densities (J) were 
calculated from the relation J = E. Estimated current 
densities in cell cultures ranged from 0.14 to 0.63 A/m
2
 (Table 
I). Since the ratio of the depth to the width (0.05 m) of the 
culture medium in each flask is less than 0.3, estimation of 
peak electric fields from the magnetic flux densities has an 
uncertainty of 1% [26]. For sham-EMF exposure (0 Hz), the 
control samples were treated as described with the plasma ray 
tube turned off.  
To test whether the radial variation in induced magnetic 
flux density across the cell culture layers had an impact on cell 
viability, the proportions of seeded cells that eventually form 
colonies (plating efficiencies) were determined in cell cultures 
placed at the different radial distances, as in Fig. 1, for 0, 100, 
and 1000 Hz exposures. In the current setting, no significant 
frequency- and location-dependent differences in plating 
efficiency were observed. For the V79 cells, the plating 
efficiency at 0 Hz (73  4%) did not differ significantly from 
those at 100 Hz (82  3%; P = 0.12) and 1000 Hz (73  5%; P 
= 0.94). Similarly, the plating efficiency for sham exposed 
MeWo cells (55  4%) was not significantly different from 
those determined when the cells were exposed to 100 Hz (62  
7%; P = 0.30) and 1000 Hz (57  6%; P = 0.82).  
 
C. Cell Culture Irradiation, Clonogenic Cell Survival and 
Radiomodulatory Effects of Electromagnetic Fields 
Pre-prepared monolayer cell cultures were irradiated at 
room temperature (20°C) at a dose rate of 1 Gy/min, using a 
Faxitron MultiRad 160 X-ray irradiator (Faxitron Bioptics, 
Tucson, AZ). Irradiation was performed at various time points 
relative to electromagnetic field exposure as described above. 
Sham-irradiated cultures were left on the turntable of the 
Faxitron X-ray irradiator for 2 min with the X-ray source 
turned off. 
The irradiated and EMF exposed cell cultures were left in 
an incubator at 37°C for 7 and 14 days (for V79 and MeWo 
cells, respectively) for colony formation. Colonies were then 
fixed in glacial acetic acid:methanol:water (1:1:8, v/v/v), 
stained with 0.01% amido black in fixative, air-dried, and 
counted. Unirradiated cultures with and without 
electromagnetic field exposure were used as controls for EMF 
and X-ray treatment, respectively. Colonies containing at least 
50 cells were deemed to have originated from single surviving 
cells and were scored. Cytotoxicity was assessed on the basis 
of a surviving fraction (SF) which was calculated from the 
relation: SF=ncol(t)/{[ncol(u)/ncell(u)]ncell(t)}, where ncol(t) and 
ncol(u) denote the number of colonies counted in treated and 
untreated samples, respectively. ncell(t) and ncell(u) are the 
number of cells seeded in treated and untreated cultures, 
respectively. Three independent experiments were performed 
for each time point and experimental arm. Radiosensitivity 
was expressed in terms of the surviving fraction at 2 Gy. 
To investigate the influence of EMF exposure on 
radiosensitivity, the interaction between EMF and X-rays was 
expressed as a modifying factor (MF), given as the ratio of 
surviving fraction at 2 Gy in the absence EMF to that in the 
presence of EMF. The criteria for inhibition, no effect, and 
enhancement of radiosensitivity by EMF are MF<1.0, 
MF=1.0, and MF>1.0, respectively.  
 
D. Statistical Analysis 
Statistical analyses were performed using the GraphPad 
Prism (GraphPad Software, San Diego, CA) computer 
program. To compare two data sets, the unpaired two-sided t-
test was used. A P-value of less than 0.05 indicates a 
statistically significant difference between the data sets. Data 
were presented as the mean (±SEM) from at least 3 
independent experiments. For each experiment, 3 replicates 
were assessed.  
III. RESULTS 
Radiosensitivity was expressed in terms of the surviving 
fraction at 2 Gy. Fig. 2 shows the relationship between 
radiosensitivity of the Chinese hamster lung fibroblasts (V79) 
and the time of X-ray treatment after EMF exposure. For time 
intervals ranging from 0 to 2 h, exposure to fields of 100 and 
1000 Hz had no effect on radiosensitivity, with a modifying 
factor of ~0.99. Also, no effect on radiosensitivity was 
observed when cells were irradiated 6 h after EMF exposure 
(Fig. 2). However, the cells were marginally sensitized when 
X-irradiation occurred 4 h after EMF treatment, giving 
modifying factors of 1.09 ± 0.09 and 1.30 ± 0.25 for the 100 
and 1000 Hz fields, respectively. 
Irradiating V79 cells to 2 Gy prior to exposure to a 100 Hz 
field yielded a small radioprotection, while a 1000 Hz field 
exposure resulted in a slight radiosensitization (Fig. 3). The 
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4 
corresponding modifying factors ranged from 0.87 to 0.96 and 
from 1.06 to 1.13. These effects were independent of the time 
interval between X-irradiation and EMF exposure. 
  Data for cell survival at 2 Gy in the human melanoma 
cells (MeWo), when cells were exposed to either a 100 or 
1000 Hz electromagnetic field before being irradiated with X-
rays, are presented in Fig. 4. For all time intervals between 
EMF and X-ray treatment, pre-treatment with a 100 Hz field 
resulted in significant radioprotection, with modifying factors 
ranging from 0.68 ± 0.04 to 0.79 ± 0.01. On the contrary, pre-
exposure to a 1000 Hz field yielded significant 
radiosensitization, giving modifying factors between 1.35 ± 
0.02 and 1.64 ± 0.19. The radiation modifying factors when 
cells were irradiated at 2 h and 4 h after EMF exposure 
emerged as 1.51 and 1.52, respectively (Fig. 4).  
When the MeWo cells were irradiated to 2 Gy of X-rays 
followed by exposure to a 100 Hz EMF, the cells were 
rendered more radiosensitive, as shown in Fig. 5, with 
modifying factors ranging from 1.34 to 1.76. However, when 
X-ray exposure was followed by treatment with a 1000 Hz 
EMF, the cells were less radiosensitive with modifying factors 
ranging from 0.90 to 0.94.  
 
IV. DISCUSSION 
Electromagnetic fields are known to affect the normal 
functioning of cells and their effects differ depending on the 
cell type. In this investigation, the Chinese hamster lung 
fibroblasts (V79) were used to represent normal tissue, while 
the human melanoma cells (MeWo) represented tumor cells. 
The current data suggest that normal tissue and cancerous cells 
do not respond to all electromagnetic fields in the same way. 
While pre-exposure of the V79 cells to both 100 and 1000 Hz 
fields followed by 2 Gy of X-rays had no effect when cells 
were irradiated within 2 h of EMF exposure, significant 
radioprotection and radiosensitization was seen in the MeWo 
cells for the 100 and 1000 Hz fields over all time points 
investigated (Fig. 2 and Fig. 4). The findings that the 
fibroblasts were protected by the 1000 Hz field exposure when 
cells were irradiated 1 h after EMF exposure and that both 
fields were radiosensitizing at an interval of 4 h, suggest that 
an EMF of a 1000 Hz may potentiate tumor radiosensitivity 
with little or no normal tissue effect if radiation is given within 
1 h of EMF exposure. 
Interestingly, the 100 Hz field protected and sensitized pre-
irradiated V79 and MeWo cells, respectively (Fig. 3 and Fig. 
5). This phenomenon, over all time points, indicated that 
exposing tumor cells to a 100 Hz electromagnetic field within 
6 h of administering a fraction of radiation dose might have a 
significant level of therapeutic benefit. It is currently not clear 
why these cell lines behave differently when exposed to the 
two electromagnetic fields, and in a manner dependent on the 
sequence of EMF exposure and X-irradiation. However, 
sensitization of the cells when they are exposed to EMF 
followed by X-ray could be due to many different 
mechanisms, including the EMF causing an influx of calcium 
ions, with an alteration in homeostasis triggering mitotic 
division [27]. This process would prompt otherwise dormant 
cells to start dividing. Actively dividing cells are more prone 
to radiation-induced cell death than dormant cells, and the net 
effect will be a low level of cell survival. Also, the observed 
radiosensitization may have been caused by intracellular 
cascades, such as activation of matrix metalloproteinases by 
reactive oxygen species, the concentration of which is known 
to be increased by exposure to magnetic fields [17], [28]. 
Reactive oxygen species act as radiosensitizers. Furthermore, 
the radiosensitization can result from calcium-ion overload, 
which is highly toxic and leads to cell suicide, by activating 
proteases and phospholipases [18], [27]. Cells carrying 
radiation-induced DNA damage can be expected to be more 
radiosensitive when exposed to EMF, as the electromagnetic 
field can disorient charged amino acids, resulting in a change 
in the 3-dimensional structure of proteins and thus disturbing 
their function [29]. This could be a reason for the sensitization 
seen when cells are exposed to EMF after X-irradiation, since 
the enzymes responsible for repairing X-ray damage may be 
rendered non-functional by the subsequent exposure to 
appropriate resonant frequencies [23]. This can result in non-
repaired damage and ultimate cell death. However, this cannot 
explain the radiosensitization seen 6 h after X-irradiation (Fig. 
3 and Fig. 5), as most all DNA repair should be completed. 
The radiosensitization seen when pre-irradiated cells were 
exposed to EMF may be due to dysregulation of ion channels 
and alteration of hormones leading to cells adopting different 
signaling pathways, some of which may trigger cell death 
[30]. Cells become more radiosensitive when more damage is 
inflicted on them by another form of treatment. These findings 
can also be attributed to cells being rendered sensitive to cell 
type-specific radiofrequency fields [24].  
In conclusion, the data reported here demonstrate that 
electromagnetic fields have the desirable toxic and protective 
effects on tumor and normal cells, respectively, if appropriate 
frequencies are administered at the right times relative to X-
irradiation. Electromagnetic fields, therefore, have the 
potential of being used in conjunction with radiotherapy to 
reduce the total radiation absorbed dose administered to 
patients. This can have a significant positive impact on the 
management of patients with superficial tumors, especially 
those who are immune compromised. To fully realize the 
potential of this therapeutic approach, additional studies 
involving a broader range of cell lines are required to 
understand the mechanism underlying the interaction between 
electromagnetic fields and ionizing radiation.  
 
 
REFERENCES 
[1] T. Kaminuma, K. Karasawa, N. Hanyu, T.-C. Chang, G. Kuga, N. 
Okano, N. Kubo, Y. Okuma, Y. Nagata, Y. Maeda, and A. 
Ajisawa, “Acute adverse effects of radiation therapy on HIV-
positive patients in Japan: study of 31 cases at Tokyo Metropolitan 
Komagome Hospital,” J. Radiat. Res., vol. 51, pp. 749-753, 2010. 
[2] A. Jemal, F. Bray, D. Forman, M. O’Brien, J. Ferlay, M. Center, 
and D. M. Parkin, “Cancer burden in Africa and opportunities for 
prevention,” Cancer, vol. 118, pp. 4372-4384, 2012. 
[3] J. P. Goodrich, “Experimental modification of radiosensitivity of 
Page 4 of 13Transactions on Plasma Science
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Stellenbosch University  https://scholar.sun.ac.za
For Review Only
> REPLACE THIS LINE WITH YOUR PAPER IDENTIFICATION NUMBER (DOUBLE-CLICK HERE TO EDIT) < 
 
5 
embryonic cells,” Radiol., vol. 40, pp. 179-187, 1943. 
[4] V. A. Potiron, R. Abderrahmani, K. Clément-Colmou, S. 
Marionneau-Lambot, T. Oullier, F. Paris, and S. Supiot. (2013, 
Dec.). Improved functionality of the vasculature during 
conventionally fractionated radiation therapy of prostate cancer. 
PLoS One [Online]. 8(12), p. e84076. Available: 
http://dx.doi.org/10.1371/journal.pone.0084076. 
[5] S. Maleka, A. Serafin, R. Hamunyela, M. Hamid, D. Achel, and J. 
Akudugu, “NVP-BEZ235 enhances radiosensitivity of human 
prostate cancer cells but acts as a radioprotector to normal prostate 
cells,” J. Cancer Biol. Therap., vol. 1, pp. 38-45, 2015. 
[6] R. Hamunyela, A. Serafin, M. Hamid, S. Maleka, D. Achel, and J. 
Akudugu, “A cocktail of specific inhibitors of HER-2, PI3K, and 
mTOR radiosensitises human breast cancer cells,” J. Cancer Biol. 
Therap., vol. 1, pp. 46-56, 2015. 
[7] D. Janigro, C. Perju, V. Fazio, K. Hallene, G. Dini, M. K. Agarwal, 
and L. Cucullo, “Alternating current electrical stimulation 
enhanced chemotherapy: a novel strategy to bypass multidrug 
resistance in tumor cells,” BMC Cancer, vol. 6, p. 72, 2006. doi: 
10.1186/1471-2407-6-72. 
[8] Verginadis, A. Velalopoulou, I. Karagounis, Y. Simos, D. Peschos, 
S. Karkabounas, and A. Evangelou, “Beneficial effects of 
electromagnetic radiation in cancer,” in Electromagnetic Radiation, 
S. O. Bashir, Ed. Shanghai: InTech, 2012, pp. 249-268. 
[9] E. D  Kirson, V. Dbalý, F. Tovaryš, J. Vymazal, J. F. Soustiel, A. 
Itzhaki, D. Mordechovich, S. Steinberg-Shapira, Z. Gurvich, R. 
Schneiderman, Y. Wasserman, M. Salzberg, B. Ryffel, D. 
Goldsher, E. Dekel, and Y. Palti, “Alternating electric fields arrest 
cell proliferation in animal tumor models and human brain 
tumors,” Proc. Natl. Acad. Sci. U.S.A., vol. 104, pp. 10152-10157, 
2007. 
[10] A. Barbault, F. P. Costa, B. Bottger, R. F. Munden, F. Bomholt, N. 
Kuster, and B. Pasche, Amplitude-modulated electromagnetic 
fields for the treatment of cancer: Discovery of tumor-specific 
frequencies and assessment of a novel therapeutic approach,” J. 
Exp. Clin. Cancer Res., vol. 28, p. 51, 2009. doi: 10.1186/1756-
9966-28-51.  
[11] M. Simkó, R. Kriehuber, D. G. Weiss, and R. A. Luben, “Effects of 
50 Hz EMF exposure on micronucleus formation and apoptosis in 
transformed and nontransformed human cell lines,” 
Bioelectromagnetics, vol. 19, pp. 85-91, 1998. 
[12] S. Tofani, D. Barone, M. Cintorino, M. M. de Santi, A. Ferrara, R. 
Orlassino, P. Ossola, F. Peroglio, K. Rolfo, and F. Ronchetto. 
“Static and ELF magnetic fields induce tumor growth inhibition 
and apoptosis,” Bioelectromagnetics, vol. 22, pp. 419-428, 2001. 
[13] R. Sarimov, E. Markova, F. Johansson, D. Jenssen, and I. Belyaev, 
“Exposure to ELF magnetic field tuned to Zn inhibits growth of 
cancer cells,” Bioelectromagnetics, vol. 26, pp. 631-638, 2005. 
[14] M. Blank and R. Goodman, “Electromagnetic fields stress living 
cells,” Pathophysiology, vol. 16, pp. 71-78, 2009. 
[15] R. Goodman and A. S. Henderson, “Transcription and translation 
in cells exposed to extremely low frequency electromagnetic 
fields,” Bioelectrochem. Bioenerg., vol. 25, pp. 335-355, 1991. 
[16] S. Yamaguchi, M. Ogiue-Ikeda, M. Sekino, and S. Ueno, “Effects 
of pulsed magnetic stimulation on tumour development and 
immune functions in mice,” Bioelectromagnetics, vol. 27, pp. 64-
72, 2006. 
[17] C. Morabito, S. Guarnieri, G. Fanò, and M. A. Mariggiò, “Effects 
of acute and chronic low frequency electromagnetic field exposure 
on PC12 cells during neuronal differentiation,” Cell. Physiol. 
Biochem., vol. 24, pp. 947-958, 2010. 
[18] F. Artacho-Cordón, M. M. Salinas-Asensio, I. Calvente, S. Ríos-
Arrabal, J. León, E. Román-Marinetto, N. Olea, and M. I. Núñez, 
“Could radiotherapy effectiveness be enhanced by electromagnetic 
field treatment?,” Int. J. Mol. Sci., vol. 14, pp. 14974-14995, 2013. 
[19] G. L.-Y. Cheing, X. Li, L. Huang, R. L.-C. Kwan, and K.-K. 
Cheung, “Pulsed electromagnetic fields (PEMF) promote early 
wound healing and myofibroblast proliferation in diabetic rats,” 
Bioelectromagnetics, vol. 35, pp. 161-169, 2014. 
[20] E. D. Kirson, Z. Gurvich, R. Schneiderman, E. Dekel, A. Itzhaki, 
Y. Wasserman, R. Schatzberger, and Y. Paltiet, “Disruption of 
cancer cell replication by alternating electric fields,” Cancer Res., 
vol. 64, pp. 3288-3295, 2004. 
[21] M. Lupke, J. Frahm, M. Lantow, C. Maercker, D. Remondini, F. 
Bersani, and M. Simkó, “Gene expression analysis of ELF-MF 
exposed human monocytes indicating the involvement of the 
alternative activation pathway,” BBA-Mol. Cell Res., vol. 1763, pp. 
402-412, 2006. 
[22] American Cancer Society, “Questionable methods of cancer 
management: Electronic devices,” CA Cancer J. Clin., vol. 44, pp. 
115-127, 1994. 
[23] R. T. V. Agulan, E. M.F. Capule, R. F. Pobre. (2015, March). 
Effect of pulsed electromagnetic fields on colon cancer cell lines 
(HCT 116) through cytotoxicity test. Presented at the DLSU 
Research Congress, vol. 3, De La Salle University, Manila, 
Philippines. [Online]. Available: 
http://www.dlsu.edu.ph/conferences/dlsu_research_congress/2015/
proceedings/FNH/010FNH_Pobre_RF.pdf 
[24] W. Zimmerman, H. Jimenez, M. J. Pennison, I. Brezovich, D. 
Morgan, A. Mudry, F. P. Costa, A. Barbault, and B. Pasche, 
“Targeted treatment of cancer with radiofrequency electromagnetic 
fields amplitude-modulated at tumor-specific frequencies,” Chin. J. 
Cancer, vol. 32, pp. 573-581, 2013. 
[25] E. D. Mantiply, K. R. Pohl, S. W. Poppell, and J. A. Murphy, 
“Summary of measured radiofrequency electric and magnetic fields 
(10 kHz to 30 GHz) in the general and work environment,” 
Bioelectromagnetics, vol. 18, pp. 563-577, 1997. 
[26] H. Bassen, T. Litovitz, M. Penafiel, and R. Meister, “ELF in vitro 
exposure systems for inducing uniform electric and magnetic fields 
in cell culture media,” Bioelectromagnetics, vol. 13, pp. 183-198, 
1992. 
[27] P. Pinton, C. Giorgi, R. Siviero, E. Zecchini, and R. Rizzuto, 
“Calcium and apoptosis: ER-mitochondria Ca2+ transfer in the 
control of apoptosis,” Oncogene, vol. 27, pp. 6407-6418, 2008. 
[28] H. C. Lai and N. P. Singh, “Medical applications of 
electromagnetic fields,” in Electromagnetic Phenomena and 
Health - A Continuing Controversy?, IOP Conference Series: Earth 
and Environmental Science, IOP Publishing (UK), 2010, pp. 
10:012006.  
[29] R. G. Menéndez, “Three molecular mechanisms to explain some 
biological effects of electromagnetic fields and hypogravity,” Med. 
Hypotheses, vol. 52, pp. 239-245, 1999. 
[30] S. Orrenius, M. J. McCabe Jr, and P. Nicotera, “Ca2+-dependent 
mechanisms of cytotoxicity and programmed cell death,” Toxicol. 
Lett., vols. 64/65, pp. 357-364, 1992.  
 
 
 
 
 
 
 
 
 
 
 
 
    
    
 
  
Page 5 of 13 Transactions on Plasma Science
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Stellenbosch University  https://scholar.sun.ac.za
For Review Only
> REPLACE THIS LINE WITH YOUR PAPER IDENTIFICATION NUMBER (DOUBLE-CLICK HERE TO EDIT) < 
 
6 
TABLE I 
ESTIMATED PEAK MAGNETIC FLUX DENSITY (B), ELECTRIC FIELD STRENGTH 
(E), AND CURRENT DENSITY (J) INDUCED AT A DISTANCE (d) FROM PLASMA 
RAY TUBE 
 
 
 
 
 
 
 
Fig. 1.  (a) Photograph of the electromagnetic field (EMF) exposure system. 
(b) A 2-dimensional schematic diagram showing the top and bottom cell 
culture planes of the 226 flask matrix. In the set-up, the plasma ray tube is 
centred horizontally above the cell culture flasks, such that the induced 
magnetic field (B) is parallel to the base of a flask and the induced electric 
field (E) in the culture medium is parallel to the width of the flask. 
 
 
 
Fig. 2.  Clonogenic cell survival at 2 Gy in Chinese hamster lung fibroblasts 
(V79), when cells were exposed to a 100 or 1000 Hz electromagnetic field 
(EMF) prior to X-irradiation, as a function of time between EMF exposure 
and X-ray treatment. Data points are means ± SEM of 3 independent 
experiments. Horizontal dashed line represents the surviving fraction at 2 Gy 
without EMF exposure. 
 
 
 
 
Fig. 3.  Clonogenic cell survival at 2 Gy in Chinese hamster lung fibroblasts 
(V79), when cells were exposed to X-irradiation prior to a 100 or 1000 Hz 
electromagnetic field (EMF), as a function of time between X-ray treatment 
and EMF exposure. Data points are means ± SEM of 3 independent 
experiments. Horizontal dashed line represents the surviving fraction at 2 Gy 
without EMF exposure. 
 
 
 
  
d (cm) B (T)  E (V/m)  J (A/m
2) 
10.0  1.44 0.42 0.63 
12.4 0.94 0.28 0.42 
14.8 0.66 0.20 0.30 
17.2 
19.2 
22.0  
0.49 
0.39 
0.30 
0.15 
0.12 
0.09 
0.23 
0.18 
0.14 
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Fig. 4.  Clonogenic cell survival at 2 Gy in human melanoma cells (MeWo), 
when cells were exposed to a 100 or 1000 Hz electromagnetic field (EMF) 
prior to X-irradiation, as a function of time between EMF exposure and X-ray 
treatment. Data points are means ± SEM of 3 independent experiments. 
Horizontal dashed line represents the surviving fraction at 2 Gy without EMF 
exposure. 
 
 
 
 
 
Fig. 5.  Clonogenic cell survival at 2 Gy in human melanoma cells (MeWo), 
when cells were exposed to X-irradiation prior to a 100 or 1000 Hz 
electromagnetic field (EMF), as a function of time between X-ray treatment 
and EMF exposure. Data points are means ± SEM of 3 independent 
experiments. Horizontal dashed line represents the surviving fraction at 2 Gy 
without EMF exposure. 
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